Oura
Oura Signs Licensing Agreements With Smart Ring Rivals Following ITC Ruling
The Finnish wearable company has signed new agreements with RingConn and Omate, aiming to establish clearer intellectual property standards in […]
Oura Adds Long-Term Stress Tracking, Other Preventive Health Features
Fresh off an $11B valuation, Oura is rolling out updates including a "Cumulative Stress" measurement, along with a redesigned app interface.
Oura’s $11B Valuation Signals Investor Confidence in Preventive Health
Oura has raised $900 million at an $11 billion valuation as smart rings surge and the U.S. government pushes wearables for preventive health.
Peloton Enters Menopause Care as Wellness Brands Race To Aid Women in Midlife
Peloton is partnering with Respin Health to launch a research study on how targeted exercise can improve menopause-related symptoms.
Ultrahuman Adds AI-Powered Medical Advice, Expands Blood-Testing Service
Smart ring maker Ultrahuman has unveiled two initiatives to make preventive healthcare more accessible: Vision Cloud and Blood Vision Essentials.
UBS Event Explores What’s Next in Booming Global Wellness Market
From AI wearables to GLP-1s and social fitness, UBS’s event spotlighted the innovations driving the $2 trillion wellness market.
Oura Sees Ring Sales Surge Amid Rumored $11B Valuation
Oura has sold over two million units in the past year alone and is on track for $1 billion in revenue in 2025 as the smart ring market booms.
Smart Rings Are Dominating the Fitness Wearable Market, Especially Among Gen Z
Smart rings now make up 75% of fitness tracker revenue, with Gen Z driving adoption as RFK Jr. pushes for wearables to become public health policy.
Fitness Wearables Market Set To Hit $190B, but Data & Battery Life Hurdles Remain
Fitness trackers are expanding into healthcare, corporate wellness and women’s health, yet privacy risks and battery life remain hurdles.
Oura Gets Another Win Against Ultrahuman as Indian Court Tosses Patent Case
The Delhi High Court has dismissed Ultrahuman’s lawsuit against Oura, citing “wilful and deliberate” non-disclosure of U.S. trade rulings.